Reach Us +32 25889658


HIPEC in Colorectal Cancer with Peritoneal Carcinomatosis

HIPEC in colorectal malignant growth with peritoneal carcinomatosis studies reveal that the mix of broad cytoreductive medical procedure with hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) has been accounted for to confer a benefit in survival of patients with peritoneal carcinomatosis from colorectal cancer. One investigation demonstrated a middle generally survival of 19.2 months in patients treated with CRS and HIPEC. This review shows all the randomized preliminaries with better standardization of HIPEC procedures in order to develop guidelines concerning the P.C. management.
Author(s): Spiliotis John

Abstract | PDF

Share this  Facebook  Twitter  LinkedIn  Google+
30+ Million Readerbase
Recommended Conferences
Flyer image
Abstracted/Indexed in
  • Google Scholar
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Secret Search Engine Labs